Search research articles
Contact Us
Filters
Showing results (161-170 of 303) with videos related to
Page
of 31
Sort By:
Leukemia
|
March 11, 2020
Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids
Daniela Hernandez, Laura Palau, Kelly Norsworthy, et al.
American Journal of Hematology
|
January 9, 2026
Long-Term Outcomes of Stem Cell Transplant in Older Patients With Acute Myeloid Leukemia Treated With Venetoclax-Based Therapies
Keith W Pratz, Courtney D DiNardo, Martha Arellano, et al.
Blood
|
September 27, 2012
Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML
Amy Sexauer, Alexander Perl, Xiaochuan Yang, et al.
Leukemia & Lymphoma
|
August 28, 2010
Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation
Elizabeth A Griffiths, Steven D Gore, Craig Hooker, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
|
June 30, 2022
What the American Journal of Critical Care Junior Peer Reviewers Were Reading During the First Year of the Program: Caring for Patients With COVID-19
L Douglas Smith, Jennifer Berube, Mintie Indar-Maraj, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 16, 2014
Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapy
Mindy Leech, Lawrence Morris, Moishe Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features
Judith E Karp, B Douglas Smith, Ivana Gojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2012
Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro
Erin L Schenk, Brian D Koh, Karen S Flatten, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia
Susan O'Brien, Ellin Berman, Joseph O Moore, et al.
Seminars in Arthritis and Rheumatism
|
May 19, 2012
Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort
Alan M Borowoy, Janet E Pope, Earl Silverman, et al.
Page
of 31
Search research articles
Search
Showing results (161-170 of 303) with videos related to
Sort By:
Page
of 31
Leukemia
|
March 11, 2020
Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids
Daniela Hernandez, Laura Palau, Kelly Norsworthy, et al.
American Journal of Hematology
|
January 9, 2026
Long-Term Outcomes of Stem Cell Transplant in Older Patients With Acute Myeloid Leukemia Treated With Venetoclax-Based Therapies
Keith W Pratz, Courtney D DiNardo, Martha Arellano, et al.
Blood
|
September 27, 2012
Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML
Amy Sexauer, Alexander Perl, Xiaochuan Yang, et al.
Leukemia & Lymphoma
|
August 28, 2010
Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation
Elizabeth A Griffiths, Steven D Gore, Craig Hooker, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
|
June 30, 2022
What the American Journal of Critical Care Junior Peer Reviewers Were Reading During the First Year of the Program: Caring for Patients With COVID-19
L Douglas Smith, Jennifer Berube, Mintie Indar-Maraj, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 16, 2014
Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapy
Mindy Leech, Lawrence Morris, Moishe Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features
Judith E Karp, B Douglas Smith, Ivana Gojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2012
Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro
Erin L Schenk, Brian D Koh, Karen S Flatten, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia
Susan O'Brien, Ellin Berman, Joseph O Moore, et al.
Seminars in Arthritis and Rheumatism
|
May 19, 2012
Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort
Alan M Borowoy, Janet E Pope, Earl Silverman, et al.
Page
of 31